Karyopharm to Present at B. Riley Securities Oncology Investor Conference
- Friday, January 21, 2022, 7:16
- PR Newswire
- Add a comment
NEWTON, Mass., Jan. 21, 2022 /PRNewswire/ — Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that Richard Paulson, President and Chief Executive Officer of Karyopharm, will present virtually at the B….
About the Author
admin has written 21717 stories on this site.